Friday, July 10, 2026

pharma · No medical condition. · No medical condition

Tillomed Laboratories

Laboratorios Tillomed Spain is a pharma organization headquartered in EU. Primary therapeutic focus areas include No medical condition., No medical condition, Hormone receptor-positive early breast cancer in post-menopau

Luton, GB HQ
1 Employees
EMA registrant Type
Company details
Clinical program

CLOBOF3-17IA03

Phase 3 · small molecule · Inflammation and pain associated with ocular surgery

CLOBOF3-17IA03 for Inflammation and pain associated with ocular surgery is a Phase 3 program (small_molecule) at Laboratorios Tillomed Spain S.L.U with 1 ClinicalTrials.gov record(s).

Internal code CLOBOF3-17IA03

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Laboratorios Tillomed Spain S.L.U
Phase
Phase 3
Modality
small_molecule
Indication
Inflammation and pain associated with ocular surgery
Status
active
Trials
1